Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole - 09/08/11
Doi : 10.1016/j.jpeds.2006.04.027
Nerissa C. Kreher, MD ⁎ 
, Ora Hirsch Pescovitz, MD, Paul Delameter, MD, Anatoly Tiulpakov, MD, Ze’ev Hochberg, MD, DSc
, Ora Hirsch Pescovitz, MD, Paul Delameter, MD, Anatoly Tiulpakov, MD, Ze’ev Hochberg, MD, DSc Department of Pediatrics, Section of Pediatric Endocrinology and Diabetology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana (NCK, currently with Serono, Inc., Rockland, MA); Endocrine and Diabetes Care Center, Toledo, Ohio; Institute of Pediatric Endocrinology, Endocrinological Research Center, Moscow, Russia; and the Division of Endocrinology, Meyer Children’s Hospital, Rambam Medical Center and Technion, Israel Institute of Technology, Haifa, Israel
Reprint requests: Nerissa C. Kreher, MD, Serono, Inc., One Technology Place, Rockland, MA 02370.Résumé |
This report describes the use of bicalutamide and anastrozole in two subjects with familial male-limited precocious puberty. Clinical improvements include decreased facial acne and pubic hair. Most importantly, a marked decrease in growth velocity and skeletal advancement has been achieved.
Le texte complet de cet article est disponible en PDF.Abbreviations : ΔBA/ΔCA, FSH, FMPP, GV, GnRH, LH, PAH, PCR
Plan
© 2006
Mosby, Inc. Tous droits réservés.
Vol 149 - N° 3
P. 416-420 - septembre 2006 Retour au numéro
Article précédent
- Brachial artery aneurysms in Menkes disease
- Sarah C. Godwin, Thomas Shawker, Benjamin Chang, Stephen G. Kaler
- Urinary antibiotic prophylaxis may not be required in children with mild or moderate vesicoureteral reflux following acute pyelonephritis
- Ellen R. Wald
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?